English
  1. Home
  2. Stocks
  3. Natcopharm Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Natco Pharma Share Price Natco Pharma

    Mid Cap
    ₹974.00
    +4.4 (0.45%)
    13 May, 2024 07:57 BSE: 524816 NSE: NATCOPHARMISIN: INE987B01026

    Start SIP in Natco Pharma

    Start SIP

    Natco Pharma Performance

    Day Range

    • Low 964
    • High 987
    ₹ 974

    52 Week Range

    • Low 609
    • High 1,108
    ₹ 974
    • Open Price970
    • Previous Close970
    • Volume277584

    Natco Pharma Share Price

    • Over 1 Month -0.03%
    • Over 3 Month +16.86%
    • Over 6 Month +23%
    • Over 1 Year +56.27%

    Natco Pharma Key Statistics

    P/E Ratio 13.7
    PEG Ratio 0.1
    Market Cap Cr 17,445
    Price to Book Ratio 3.6
    EPS 34.7
    Dividend 1
    Relative Strength Index 44.54
    Money Flow Index 57.32
    MACD Signal 8.1
    Average True Range 32.87
    Natco Pharma Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 6259311,048781
    Operating Expenses Qtr Cr 387488545454
    Operating Profit Qtr Cr 238442504328
    Depreciation Qtr Cr 40404038
    Interest Qtr Cr 4331
    Tax Qtr Cr 32647052
    Net Profit Qtr Cr 192360405254
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 2,437
    Operating Expenses Annual Cr 1,506
    Operating Profit Annual in Cr 845
    Depreciation Cr 151
    Interest Annual Cr 9
    Tax Annual Cr 134
    Net Profit Annual Cr 637
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 784
    Cash from Investing Activity Annual Cr -437
    Cash from Financing Annual Activity Cr -347
    Net Cash Flow Annual Cr 1
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 4,702
    Fixed Assets Annual Cr 2,297
    Total Non Current Assets Annual Cr 2,893
    Total Current Assets Annual Cr 2,495
    Total Assets Annual Cr 5,388
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 258
    ROE Annual % 14
    ROCE Annual % 16
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 40
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 7591,0311,141898
    Operating Expenses Qtr Cr 491573613559
    Operating Profit Qtr Cr 268458528339
    Depreciation Qtr Cr 44444441
    Interest Qtr Cr 5443
    Tax Qtr Cr 44718049
    Net Profit Qtr Cr 213369420276
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 2,812
    Operating Expenses Annual Cr 1,772
    Operating Profit Annual in Cr 936
    Depreciation Cr 164
    Interest Annual Cr 15
    Tax Annual Cr 147
    Net Profit Annual Cr 715
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 849
    Cash from Investing Activity Annual Cr -477
    Cash from Financing Annual Activity Cr -363
    Net Cash Flow Annual Cr 9
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 4,874
    Fixed Assets Annual Cr 2,436
    Total Non Current Assets Annual Cr 2,657
    Total Current Assets Annual Cr 3,000
    Total Assets Annual Cr 5,657
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 267
    ROE Annual % 15
    ROCE Annual % 18
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 38
    Sign Up to Know More
    Invest in Natco Pharma

    Natco Pharma Technicals

    EMA & SMA

    Current Price
    ₹974.00
    +4.4 (0.45%)
    pointer
    • Bullish Moving Average
    • ___
    • 5
    • Bearish Moving Average
    • ___
    • 11
    • 20 Day
    • ₹996.12
    • 50 Day
    • ₹977.06
    • 100 Day
    • ₹935.62
    • 200 Day
    • ₹870.34
    • 20 Day
    • ₹999.04
    • 50 Day
    • ₹988.35
    • 100 Day
    • ₹923.14
    • 200 Day
    • ₹874.67

    Natco Pharma Resistance and Support

    PIVOT
    ₹975.05
    Resistance
    First Resistance 985.80
    Second Resistance 997.60
    Third Resistance 1,008.35
    RSI 44.54
    MFI 57.32
    MACD Single Line 8.10
    MACD 2.05
    Support
    First Resistance 963.25
    Second Resistance 952.50
    Third Resistance 940.70

    Natco Pharma Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 295,659 14,679,469 49.65
    Week 576,262 32,489,629 56.38
    1 Month 686,103 33,776,843 49.23
    6 Month 882,017 38,111,964 43.21

    Natco Pharma Result Highlights

    Natco Pharma Synopsis

    NSE-Medical-Diversified

    Natco Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2351.00 Cr. and Equity Capital is Rs. 36.50 Cr. for the Year ended 31/03/2023. Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24230TG1981PLC003201 and registration number is 003201.
    Market Cap 17,445
    Sales 3,385
    Shares in Float 8.96
    No of funds 320
    Yield 0.92
    Book Value 3.78
    U/D Vol ratio 1.4
    LTDebt / Equity
    Alpha 0.18
    Beta 0.62

    Natco Pharma

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 49.71%49.71%49.71%49.76%
    Mutual Funds 4.08%5.2%7.65%9.45%
    Insurance Companies 5.58%6.04%6.34%5.57%
    Foreign Portfolio Investors 16.14%13.72%12.82%11.03%
    Financial Institutions/ Banks
    Individual Investors 20.61%21.24%19.5%20.21%
    Others 3.88%4.09%3.98%3.98%

    Natco Pharma Management

    Name Designation
    Mr. G S Murthy Chairman & Ind.Director
    Mr. V C Nannapaneni Managing Director
    Mr. Rajeev Nannapaneni Director & CEO
    Mr. T V Rao Independent Director
    Mr. D G Prasad Independent Director
    Dr. M U R Naidu Independent Director
    Dr. Leela Digumarti Independent Director
    Mr. P S R K Prasad Director & Exe. VP (Corp. Engg. Services)
    Dr. Linga Rao Donthineni Director & President (Tech. Affairs)
    Dr. Pavan Ganapati Bhat Director

    Natco Pharma Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Natco Pharma Corporate Action

    Date Purpose Remarks
    2024-05-27 Audited Results
    2024-02-14 Quarterly Results & Interim Dividend
    2023-11-14 Quarterly Results & Interim Dividend
    2023-08-09 Quarterly Results & Interim Dividend
    2023-05-29 Audited Results
    Date Purpose Remarks
    2024-02-26 INTERIM Rs.1.25 per share(62.5%)Third Interim Dividend
    2023-11-24 INTERIM Rs.1.25 per share(62.5%)Second Interim Dividend
    2023-08-22 INTERIM Rs.7.00 per share(350%)Interim Dividend
    2023-02-21 INTERIM Rs.1.25 per share (62.5%) Third Interim Dividend
    2022-11-22 INTERIM Re.0.75 per share (37.50%) Second Interim Dividend

    Natco Pharma MF Shareholding

    Name Amount(cr)
    ICICI Prudential Value Discovery Fund Growth 42,664
    Mirae Asset Large & Midcap Fund Growth 33,619
    SBI Magnum Midcap Fund Regular Growth 17,910
    Mirae Asset Midcap Fund Regular Growth 15,139
    Tata Equity P/E Fund Regular Growth 7,754

    Natco Pharma FAQs

    What is Share Price of Natco Pharma ?

    Natco Pharma share price is ₹974 As on 13 May, 2024 | 07:43

    What is the Market Cap of Natco Pharma ?

    The Market Cap of Natco Pharma is ₹17445.3 Cr As on 13 May, 2024 | 07:43

    What is the P/E ratio of Natco Pharma ?

    The P/E ratio of Natco Pharma is 13.7 As on 13 May, 2024 | 07:43

    What is the PB ratio of Natco Pharma ?

    The PB ratio of Natco Pharma is 3.6 As on 13 May, 2024 | 07:43

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.